StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Harvard Bioscience's profit margin for the twelve months ending Jun 30, 2026 was -11.9%. For fiscal 2025 it was -65.5%, against -13.2% the year before. The highest annual figure on record is 17.6% in fiscal 2010.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-65.5%−52.3
FY2024Dec 31, 2024-13.2%−10.1
FY2023Dec 31, 2023-3.0%+5.4
FY2022Dec 31, 2022-8.4%−8.2
FY2021Dec 31, 2021-0.2%+7.4
FY2020Dec 31, 2020-7.6%−3.6
FY2019Dec 31, 2019-4.0%−1.6
FY2018Dec 31, 2018-2.4%−1.3
FY2017Dec 31, 2017-1.1%+3.0
FY2016Dec 31, 2016-4.1%+13.4
FY2015Dec 31, 2015-17.5%−19.7
FY2014Dec 31, 20142.2%+3.9
FY2013Dec 31, 2013-1.7%−3.9
FY2012Dec 31, 20122.1%−1.4
FY2011Dec 31, 20113.5%−14.1
FY2010Dec 31, 201017.6%+9.1
FY2009Dec 31, 20098.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-12.8%−1.6
Q1 FY2026Mar 31, 2026-16.5%+214.7
Q4 FY2025Dec 31, 2025-12.0%−12.1
Q3 FY2025Sep 30, 2025-6.0%+15.9
Q2 FY2025Jun 30, 2025-11.2%+1.5
Q1 FY2025Mar 31, 2025-231.2%−212.0
Q4 FY2024Dec 31, 20240.1%+6.5
Q3 FY2024Sep 30, 2024-21.9%−17.0
Q2 FY2024Jun 30, 2024-12.7%−9.3
Q1 FY2024Mar 31, 2024-19.1%−21.2
Q4 FY2023Dec 31, 2023-6.5%−0.6
Q3 FY2023Sep 30, 2023-4.9%+7.8
Q2 FY2023Jun 30, 2023-3.4%−11.7
Q1 FY2023Mar 31, 20232.1%+26.0
Q4 FY2022Dec 31, 2022-5.9%−8.8
Q3 FY2022Sep 30, 2022-12.6%−12.1
Q2 FY2022Jun 30, 20228.3%+9.7
Q1 FY2022Mar 31, 2022-23.9%−21.4
Q4 FY2021Dec 31, 20212.9%+4.9
Q3 FY2021Sep 30, 2021-0.6%+4.0
Q2 FY2021Jun 30, 2021-1.4%+5.4
Q1 FY2021Mar 31, 2021-2.5%+16.5
Q4 FY2020Dec 31, 2020-2.0%−3.8
Q3 FY2020Sep 30, 2020-4.6%+5.0
Q2 FY2020Jun 30, 2020-6.8%−5.9
Q1 FY2020Mar 31, 2020-19.0%−10.6
Q4 FY2019Dec 31, 20191.8%−6.7
Q3 FY2019Sep 30, 2019-9.6%−8.7
Q2 FY2019Jun 30, 2019-0.8%+3.8
Q1 FY2019Mar 31, 2019-8.4%+6.8
Q4 FY2018Dec 31, 20188.5%+3.8
Q3 FY2018Sep 30, 2018-0.9%+1.3
Q2 FY2018Jun 30, 2018-4.6%−2.6
Q1 FY2018Mar 31, 2018-15.2%−9.3
Q4 FY2017Dec 31, 20174.6%+9.6
Q3 FY2017Sep 30, 2017-2.2%+4.3
Q2 FY2017Jun 30, 2017-2.0%–
Q1 FY2017Mar 31, 2017-5.9%–
Q4 FY2016Dec 31, 2016-5.0%–
Q3 FY2016Sep 30, 2016-6.6%–

More Harvard Bioscience figures

See a number that looks wrong?